Bull News : US Fed says no Recession will come, Biggest gain of Nasdaq in single day. Fed rate hike by 0.75% #BAJFINANCE profit rise 159%. Bajaj FinServ going to split and going to give Bonus. #BIOCON profit rise 71.4% #UBL profit rise 422.5% #DIXON profit rise 150% #NIFTY50 Chemical, Finance, Pharma, Textile stocks will go upside today.

Results on July 28 Dr Reddy's Laboratories, Nestle India, SBI Life Insurance Company, Shree Cement, Jubilant FoodWorks, Vedanta, Bajaj Finserv, Punjab National Bank, Mahindra & Mahindra Financial Services, PNB Housing Finance, SBI Cards and Payment Services, TVS Motor Company, Shriram Transport Finance, Chalet Hotels, Equitas Small Finance Bank, CMS Info Systems, GHCL, AAVAS Financiers, Intellect Design Arena, Dr Lal PathLabs, Motilal Oswal Financial Services, Nippon Life India Asset Management, NIIT, NOCIL, RITES, Sona BLW Precision Forgings, TTK Prestige, and Westlife Development will be in focus ahead of June quarter earnings on July 28. Stocks in News Tata Motors: The company posted consolidated loss at Rs 5,006.6 crore for the quarter ended June 2022, widening from loss of Rs 4,450.92 crore in same period last year on account of weak JLR performance. Consolidated revenue from operations grew by 8.3% YoY to Rs 71,934.66 crore during the same period, driven by domestic business. Jaguar Land Rover revenue declined 7.6% QoQ and 11.3% YoY to 4.4 billion pound impacted by semiconductor shortages and China lockdowns, but customer order book grew further to 2 lakh vehicles. Welspun India: The company has reported a 11.6% year-on-year decline in consolidated revenue at Rs 1,957.3 crore for the quarter ended June 2022, impacted by home textile business but flooring business fared better. Profit fell sharply by 90.4% to Rs 21.36 crore on weak operating performance at home textile business. Biocon: The pharma company recorded a 54.4% YoY growth in consolidated profit at Rs 167.40 crore for the quarter ended June 2022, partly aided by higher revenue & other income and lower tax cost. Revenue grew by 21.5% to Rs 2,139.50 crore during the same period. Exide Industries: Subsidiary Exide Energy Solutions (EESL) has executed the lease cum sale agreement for procuring land parcel admeasuring 80 acres in Bengaluru with Karnataka Industrial Areas Development Board (KIADB). The land will be used to set up state-of-the-art green field multi-gigawatt Li-ion battery cell manufacturing facility for the new-age electric mobility and stationary application businesses in India. VIP Industries: The company registered a healthy growth in consolidated profit at Rs 69.10 crore in Q1FY23, on a low base in profit at Rs 2.53 crore in Q1FY22 that affected by second Covid wave. Revenue grew by 186.4% YoY to Rs 590.61 crore during the same period. Schaeffler India: The company recorded a 76.2% year-on-year growth in profit at Rs 225.75 crore in Q2CY22 driven by healthy topline and higher operating income. Gain on sale of chain drive business also supported bottom line. Revenue grew by 41.8% YoY to Rs 1,748.83 crore during the June 2022 quarter. EIH: The company clocked consolidated profit of Rs 65.86 crore for the quarter ended June 2022 on normalisation of business, against loss of Rs 114.25 crore in same period last year. In Q1FY22, numbers were affected by second Covid wave. Revenue grew by 314% YoY to Rs 394.3 crore in Q1FY23. Hindustan Aeronautics: HAL has signed contract worth over $100 million with Honeywell for HTT-40 Engines. The company will supply and manufacture 88 TPE331-12B engines/kits along with maintenance and support services to power the Hindustan Trainer Aircraft (HTT-40). #NIFTY50 #NIFTYBANK #HAL #TATAMOTORS #BIOCON

BIOCON BUY ABOVE 340 SL 296 CBSL TGT 360 380 400 420 440+++ POSITIONAL ADVANCE LEVEL #BIOCON

*Stocks in News* Equitas Small Finance Bank: Veteran banker P N Vasudevan has resigned as the managing director and chief executive officer of Equitas Small Finance Bank, the lender informed the stock exchanges. Vasudevan, in his resignation letter, said he wants to devote his time towards social welfare through his public charitable trust. HPCL: State-run oil refiner and marketer Hindustan Petroleum Corporation posted a 34 percent decline in consolidated net profit in the March quarter to Rs 2,019 crore from Rs 3,061 crore in the year-ago period due to rise in total cost. Revenue for the quarter stood at Rs 1.07 trillion, up 24.2 percent from Rs 85,755 crore last year. Total cost rose 28 percent to Rs 1.05 trillion from Rs 81,717 crore a year ago. Operating margin for the quarter contracted sharply to 1.57 percent from 4.46 percent last year. Average gross refining margin during the year ended March 2022 was $7.19 per barrel as against $3.86 per bbl during the corresponding previous year. Godrej Consumer Products: Godrej Consumer reported a 1 percent fall in net profit for the March quarter to Rs 363 crore year-on-year as a slowdown in consumption and high commodity inflation weighed. Revenue rose 7 percent from a year ago to Rs 2,920 crore. Total cost rose 12 percent year-on-year to Rs 2,540 crore. Gland Pharma: Gland Pharma's net profit rose 10 percent to Rs 285.90 crore in the quarter ended March 2022 as against Rs 260.41 crore during the same quarter previous fiscal. Net sales rose 24.25 percent to Rs 1,103.01 crore as against Rs 887.75 crore a year ago. EBITDA margin contracted sharply to 35 percent from 40 percent year-on-year. Ashok Leyland: The company reported a 274 percent YoY jump in net profit at Rs 901.4 crore for the fourth quarter of FY22. Total income stood at Rs 8,744.3 crore during the quarter, up 24.9 percent against Rs 7,000.5 crore in the corresponding period of the preceding fiscal. Its truck market share for Q4 FY22 has improved to 30.6 percent against 28.9 percent in Q4 FY21, this is the highest market share seen in the last 11 quarters. Biocon: Subsidiary Biocon Biologics, and Viatris Inc. announced that Abevmy (bBevacizumab) is now available in Canada. Abevmy, co-developed by Biocon Biologics and Viatris, is a biosimilar to Roche's Avastin (Bevacizumab) and has been approved by Health Canada across four oncology indications. Eros International: Its board approved raising Rs 405 crore by issuing 13.50 crore warrants at a price of Rs 30 a share. #BIOCON #ASHOKLEY #GLAND #HINDPETRO #GODREJCP

ऐसे 18 स्टॉक्स जिसमें दिखेगा ऐक्शन और ट्रेड लेकर आप कर सकते हैं दमदार कमाई :- 1) CHENNAI PETROLEUM CORPORATION <GREEN> Dolly Khanna ने 263.15 रुपये/शेयर के भाव पर 10 लाख शेयर खरीदे हैं। 2) MRPL <GREEN> शेयर में आज भी तेजी जारी रहने की उम्मीद है। 3) TATA POWER <GREEN> Tata Power ने NAREDCO के साथ MoU किया। महाराष्ट्र में 5,000 EV चार्जिंग प्वाइंट लगाने के लिए MoU किया है। 4) TATA MOTORS <GREEN> कंपनी आज नई 7-सीटर इलेक्ट्रिक SUV लॉन्च करेगी। 5) VEDANTA <GREEN> Q4 में आय 27,874 करोड़ रुपये से बढ़कर 39,342 करोड़ रुपये रही, मुनाफा 7,261 करोड़ रुपये रहा। 6) SBI LIFE <GREEN> Q4 में मुनाफा 532 करोड़ रुपये से बढ़कर 672 करोड़ रुपये हुआ। कुल APE 4% बढ़कर 4,130 करोड़ रुपये हुई। 7) BIOCON <GREEN> Q4 में मुनाफा 283.9 करोड़ रुपये, आय 1,842 करोड़ से बढ़कर 2,409 करोड़ रुपये हुई। 8) HUHTAMAKI INDIA <GREEN> बोर्ड की महाराष्ट्र के अंबरनाथ में लीज होल्ड जमीन, बिल्डिंग को मोनिटाइज की मंजूरी मिली। 9) ADF FOODS <GREEN> प्रिफरेंशियल आधार पर जारी हुए वॉरंट के कनवर्जन पर विचार करने के लिए बोर्ड की बैठक होगी 10) SHRIRAM TRANSPORT FINANCE <GREEN> Q4 में मुनाफा 755 करोड़ रुपये से बढ़कर 1,086 करोड़ रुपये हुआ, NII बढ़कर 2,677 करोड़ रुपये हुई। 11) AMBUJA CEMENT (GREEN) Q1CY22 में मुनाफा 495 करोड़ रुपये रहा। आय 3,925 करोड़ और EBITDA मार्जिन 20.12% रही। 12) COLGATE (GREEN) कंपनी 21 रुपये/शेयर के भाव पर अंतरिम डिविडेंड देगी। कंपनी ने रिकॉर्ड डेट 25 मई तय किया है। 13) STERLITE TECH (RED) Q4 में 124 करोड़ रुपये के मुनाफे की जगह 22 करोड़ रुपये का घाटा हुआ। आय 1,582 करोड़ रुपये हुई। 14) BANK OF MAHARASHTRA (GREEN) Q4 में मुनाफा 165 करोड़ रुपये से बढ़कर 355 करोड़ रुपये हुआ। NII 1,383 करोड़ रुपये से बढ़कर 1,612 करोड़ रुपये हुई। Q4 में ग्रॉस NPA 4.73% से घटकर 3.94% हुआ जबकि नेट NPA 1.24% घटकर 0.97% हुआ। 15) PNB HOUSING (RED) Q4 में मुनाफा 130 करोड़ रुपये से बढ़कर 170 करोड़ रुपये हुआ। आय 1,810 करोड़ रुपये से घटकर 1,410 करोड़ रुपये हुई। 16) PERSISTENT SYSTEMS (GREEN) Nomura की खरीदारी की सलाह, लक्ष्य 5,500 रुपये/शेयर तय किया। 17) AXIS BANK (GREEN) MS की ओवरवेट की कॉल, लक्ष्य 910 रुपये/ शेयर तय किया। 18) IIFL FINANCE (GREEN) Q4 में मुनाफा 248 करोड़ रुपये से बढ़कर 321 करोड़ रुपये हुआ, आय बढ़कर 1,641 करोड़ रुपये हुई। #TATAPOWER #VEDL #SBILIFE #BIOCON #AXISBANK

BUY BIOCON 380PE AT 6.25 SL 5 BELOW RISKY WHISKY 🌅 #biocon

5 Stocks to Keep in watch list for today... #BIOCON (F&O) #BPCL (F&O) #MANALIPETC #SPIC #BANG

BIOCON Critical support Buy near 338 or 325 Sl below 310 Target 350 400 #BIOCON

ALERT: Now........BIOCON 350 CE @ 5.10 HIT........... Now you are GETTING Rs 2300 PROFIT AAY AMAZZA profit...!! DEKHLO KYA BOLA THA..ROCKET HAI CALL #BIOCON

BIOCON FUT: BUY BIOCON FUT @ 342 TARGET- 357_361 Keep SL 337 #BIOCON

OPTION_JACKPOT: BUY BIOCON 350 CE @ 4_4.10 TARGET_ 7.70_8.30 Keep SL 2.50 BUY KARO #BIOCON

OPTION_JACKPOT: BUY BIOCON 350 CE @ 4_4.10 TARGET_ 7.70_8.30 Keep SL 2.50 BUY KARO #BIOCON

YES JACKPTO CALL WHOLE PHARMA RUNNING BUY BIOCON FUT @ 341.80 TGT- 357_361 Keep SL 337 BUY BINDASSSSSSSSSS #BIOCON

BIOCON 340 CE BUY ABOVE 7.20 NOTE : I AM NOT SEBI REGISTERED . ITS ONLY MY PERSONAL VIEW AND ONLY FOR EDUCATION PURPOSE NOT FOR TRADE...... #BIOCON

Geojit Financial Services target on BIOCON Date: 07-Feb-22 Broker: Geojit Financial Services Price @ Call: 392 Target: 460 Potential: 17.35% Recommendation: BUY

BEARISH STOCKS FOR THE DAY, SELL ON RISE: #HDFC #AXISBANK #BIOCON

Today Call Performance Missed mor gud entry even though end with some gud profits #BIOCON 💥 Great from 14.1 to 18.2 =9000+ #CANBK💥💥💥JACKPOT💥💥💥from 14.1 to 19.1+ =21000+✅ #HEROMOTOCO💥💥💥JACKPOT💥💥💥from 94.5to 137+ =12000+✅ #DLF 💥 Great from 17 to 21+ =7000+ #NIFTYBANK 1st entry given 90+ points, 2nd entry got 110+ points , 3rd entry hit trail sl , 4th entry 100+ points

This view is based on volume, oi, delivery data & price action. ALL Posts are for educational purposes only & not any recommendation POSSIBLE BULLISH -> #BIOCON

Hem Securities target on BIOCON Date: 22-Jan-22 Broker: Hem Securities Price @ Call: 377 Target: 422 Potential: 11.94% Recommendation: ACCUMULATE

Sharekhan target on BIOCON Date: 21-Jan-22 Broker: Sharekhan Price @ Call: 377 Target: 470 Potential: 24.67% Recommendation: BUY

ICICIdirect.com target on BIOCON Date: 21-Jan-22 Broker: ICICIdirect.com Price @ Call: 370 Target: 410 Potential: 10.81% Recommendation: HOLD

Q2) WHY DID BIOCON JUMP 5% IN A FALLING MARKET ? ANS:- BCOZ AFTER FOREIGN BROKER UPGREADED BIOCON TO OVERWEIGHT FROM "EQUALWEIGHT" WITH A TRG PRICE @ RUPEES 465 #BIOCON

https://economictimes.indiatimes.com/markets/stocks/news/market-movers-why-did-biocon-jump-5-in-a-falling-market/articleshow/88998063.cms #BIOCON

#BAJFINANCE 270+💥💥 #BIOCON 15+ 💥💥💥JACKPOT 💥💥💥 #LTTS High 165+ #ICICIPRULI small sl mistakenly given it hit an then high 30+ #ONGC #TCS at entry level not moving

Buy Biocon 380 call @ 5.5 (Near), Target 7/9, Stoploss PAID (Hold till 14/01/22)👌✌️ #BIOCON

Buy Biocon 400 call @ 2.2, Target 2.8/3.5, Stoploss PAID (Hold till 13/01/22)💥✌️ #BIOCON

JANUARY CONTRACT BUY BIOCON 370 CE AT CMP 13.55 TGT OPEN #BIOCON

KEEP A WATCH ON #BIOCON FUT NOW AT 371 SOME GOSSIP HEARD IN STREET FOR SOME ANNOUNCEMENT TODAY

#BIOCON Biocon🔥🔥🔥 Made high 389.70 All tgt hit Keep Booking Profit... Future Enjoy💵💵💵💵

#BIOCON Biocon🔥🔥🔥 Made high 380 Tgt 2 hit Keep Booking Profit... Future Enjoy💵💵💵💵

#BIOCON 8-12-2021 ... Buy @368-dips valid till Target 385-400 or Stop< 359

Today Paid Calls Most of calls not activated #POWERGRID 💥💥💥JACKPOT 💥💥💥 10000+ #BIOCON hit sl , #ASHOKLEY hit 1st Tar Others not activated

BUY BIOCON 370 CE ABOVE 15.10 #BIOCON